MYCN and neuroblastoma: This priming regimen was also effective at sensitizing the BE(2)-C (MYCN-amplified) and NB69 neuroblastoma cell lines to vincristine treatment, although the SK-N-AS and SK-N-FI lines were not sensitized by vorinostat priming (Fig. 5C), suggesting a context dependency to this sensitization mechanism.